Nuveen Asset Management, LLC Neurocrine Biosciences Inc Transaction History
Nuveen Asset Management, LLC
- $340 Billion
- Q4 2024
A detailed history of Nuveen Asset Management, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 267,980 shares of NBIX stock, worth $37.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
267,980
Previous 345,577
22.45%
Holding current value
$37.3 Million
Previous $39.8 Million
8.06%
% of portfolio
0.01%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding NBIX
# of Institutions
657Shares Held
101MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.97 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.36 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$774 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$621 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$429 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...